Scynexis Inc last reported quarterly results on Nov 9, 2022, for the quarter ended Sep 30, 2022. It usually reports 40–46 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 40–46 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 9, 2022
40 days after quarter end
|
—
ended Sep 30, 2022
|
—
|
—
|
—
|
|
Aug 15, 2022
46 days after quarter end
|
—
ended Jun 30, 2022
|
—
|
—
|
—
|
|
May 12, 2022
42 days after quarter end
|
—
ended Mar 31, 2022
|
—
|
—
|
—
|
|
Nov 10, 2021
41 days after quarter end
|
—
ended Sep 30, 2021
|
—
|
—
|
—
|
|
Mar 5, 2018
64 days after quarter end
|
—
ended Dec 31, 2017
|
—
|
—
|
—
|
|
Oct 5, 2016
5 days after quarter end
|
—
ended Sep 30, 2016
|
—
|
—
|
—
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SCYX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Jersey City, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1178253
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.